Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-1 + Paclitaxel vs Paclitaxel+Cisplatin and 5-FU+Cisplatin in Advanced Esophageal Cancer
NCT01704690Phase 3Terminated
- Sponsor
- Peking University
- Start
- Aug 2012
- Primary completion
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tegafur in esophageal cancer, sponsored by Peking University. Started Aug 2012; status: terminated.
02
Drugs
tegafur
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on NCT01704690.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01704690.